Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2

Nasal spray innovation with micellar delivery of Cyclosporine A holds promise in combating SARS-CoV-2 infections

Simulation in In Vitro Bioequivalence for Particle Sizes

Explore Simulation-informed design in in-vitro bioequivalence trials for particle size distributions’ performance.